In a new strategic partnership with Salus Optima, IFF are developing a data driven personalized nutrition, health and wellness platform targeting metabolic health
Posted:
1 in 4 adults worldwide are affected by metabolic health issues such as obesity, pre-diabetes, high cholesterol, and pre-hypertension. IFF announced its plans for accelerated entry into the personalized nutrition sector through a strategic partnership with Salus Optima, a British-based, digitally-enabled personalized nutrition, health and wellness company. Read more here.
Exceptional clinical leadership in the 21st century demands strong communication skills and the ability to listen to colleagues. Effective leadership necessitates a cultural shift within organisations, fostering openness and innovation.
Catch up on insightful discussions from the expert panel featuring…
Congratulations on the launch of "Every Dose Used-Reducing Wasted Medicines Playbook" co-authored by Deloitte & @YewMaker on behalf of the Sustainable Medicines Partnership. Download the report here.